Automated and quantitative immunocytochemical assays of BcI*2 protein in breast carcinomas
1997

Bcl-2 Protein Expression in Breast Carcinomas

Sample size: 218 publication Evidence: moderate

Author Information

Author(s): C Charpin, S Garcia, C Bouvier, B Devictor, L Andrac, M-N Lavaut, C Allasia

Primary Institution: Department of Pathology, Faculté de Médecine Timone and Department of Pathology, Hôpital Nord Marseilles, France

Hypothesis

The study investigates the expression of the bcl-2 gene in human breast carcinomas and its correlation with prognostic indicators.

Conclusion

Bcl-2 protein expression is inversely related to tumor grade and associated with hormone receptor status in breast carcinomas.

Supporting Evidence

  • Bcl-2 expression was detected in 78% of the breast carcinomas studied.
  • An inverse relationship was observed between Bcl-2 expression and tumor grades.
  • Bcl-2 expression was significantly associated with ER-positive tumors.
  • Bcl-2 protein expression may be involved in response to endocrine therapy.

Takeaway

This study looked at a protein called Bcl-2 in breast cancer samples to see how it relates to tumor characteristics. They found that lower grades of tumors had more Bcl-2, which might help doctors understand how to treat patients better.

Methodology

The study used immunohistochemical analysis on frozen sections of breast carcinoma samples to evaluate Bcl-2 protein expression.

Potential Biases

Potential biases may arise from the subjective nature of semiquantitative analysis in previous studies.

Limitations

The study's results may not be directly comparable to previous studies due to variations in methods of detection.

Participant Demographics

Mean age of participants was 56.7 years, with a range from 32 to 83 years.

Statistical Information

P-Value

P < 0.0001

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication